Owl Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Deciduous Therapeuticsdeciduoustx.comJun 2019
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
PartnerJennifer Fonstad· solo GP
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)quadraScope Venture FundAxial VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.